Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode:
Device Week, 19 June 2020 – American Diabetes Association Conference Wrap-Up
This week's Device Week podcast covers the recent American Diabetes Association conference, which was held online for the first time. The major diabetes device makers – Abbott, Medtronic and Dexcom – used the meeting to announce new clinical data and explain their diabetes product pipeline to customers and investors.
More from R&D
• By
European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.
• By
The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.
• By
Ultrahuman seeks to “create an environment that aligns with our bodies" by linking environmental parameters collected by Ultrahuman Home to health physiology, measured by the Ultrahuman Ring Air.
• By
The rallying cry to start as early as possible has become increasingly common in the world of medical device development. Innovation expert Dr. Stuart Grant challenges this conventional wisdom, asking: Is "sooner" truly better, or is there a smarter path to market for your medical device?
More from Business
• By
The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.
• By
Despite near-term cost pressures, Intuitive Surgical is expanding manufacturing and R&D in North America and Europe to meet demand for Ion, X and Xi systems.
• By
Capital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.